SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-155988
Filing Date
2023-05-30
Accepted
2023-05-30 07:11:05
Documents
16
Period of Report
2023-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d501860d8k.htm   iXBRL 8-K 64866
2 EX-2.1 d501860dex21.htm EX-2.1 522613
3 EX-4.1 d501860dex41.htm EX-4.1 21620
4 EX-99.1 d501860dex991.htm EX-99.1 19511
  Complete submission text file 0001193125-23-155988.txt   940923

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA grna-20230529.xsd EX-101.SCH 4437
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grna-20230529_def.xml EX-101.DEF 13807
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE grna-20230529_lab.xml EX-101.LAB 23092
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grna-20230529_pre.xml EX-101.PRE 14775
10 EXTRACTED XBRL INSTANCE DOCUMENT d501860d8k_htm.xml XML 5678
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39894 | Film No.: 23971366
SIC: 2836 Biological Products, (No Diagnostic Substances)